235 related articles for article (PubMed ID: 26290198)
21. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
[TBL] [Abstract][Full Text] [Related]
22. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
Rogueda PG; Traini D
Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
[TBL] [Abstract][Full Text] [Related]
23. The History of Therapeutic Aerosols: A Chronological Review.
Stein SW; Thiel CG
J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):20-41. PubMed ID: 27748638
[TBL] [Abstract][Full Text] [Related]
24. Formulation techniques for high dose dry powders.
Brunaugh AD; Smyth HDC
Int J Pharm; 2018 Aug; 547(1-2):489-498. PubMed ID: 29778822
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary aerosol delivery and the importance of growth dynamics.
Haddrell AE; Lewis D; Church T; Vehring R; Murnane D; Reid JP
Ther Deliv; 2017 Dec; 8(12):1051-1061. PubMed ID: 29125064
[TBL] [Abstract][Full Text] [Related]
26. Inhaled formulations and pulmonary drug delivery systems for respiratory infections.
Zhou QT; Leung SS; Tang P; Parumasivam T; Loh ZH; Chan HK
Adv Drug Deliv Rev; 2015 May; 85():83-99. PubMed ID: 25451137
[TBL] [Abstract][Full Text] [Related]
27. Propellant-driven metered-dose inhalers for pulmonary drug delivery.
Smyth HD
Expert Opin Drug Deliv; 2005 Jan; 2(1):53-74. PubMed ID: 16296735
[TBL] [Abstract][Full Text] [Related]
28. The role of disposable inhalers in pulmonary drug delivery.
de Boer AH; Hagedoorn P
Expert Opin Drug Deliv; 2015 Jan; 12(1):143-57. PubMed ID: 25374325
[TBL] [Abstract][Full Text] [Related]
29. Electrostatics and inhaled medications: influence on delivery via pressurized metered-dose inhalers and add-on devices.
Mitchell JP; Coppolo DP; Nagel MW
Respir Care; 2007 Mar; 52(3):283-300. PubMed ID: 17328827
[TBL] [Abstract][Full Text] [Related]
30. Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.
Walenga RL; Longest PW
J Pharm Sci; 2016 Jan; 105(1):147-59. PubMed ID: 26852850
[TBL] [Abstract][Full Text] [Related]
31. Assessment methods of inhaled aerosols: technical aspects and applications.
Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979
[TBL] [Abstract][Full Text] [Related]
32. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
[TBL] [Abstract][Full Text] [Related]
33. Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics.
Hickey AJ; Mansour HM; Telko MJ; Xu Z; Smyth HD; Mulder T; McLean R; Langridge J; Papadopoulos D
J Pharm Sci; 2007 May; 96(5):1282-301. PubMed ID: 17455324
[TBL] [Abstract][Full Text] [Related]
34. Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics.
Hickey AJ; Mansour HM; Telko MJ; Xu Z; Smyth HD; Mulder T; McLean R; Langridge J; Papadopoulos D
J Pharm Sci; 2007 May; 96(5):1302-19. PubMed ID: 17455364
[TBL] [Abstract][Full Text] [Related]
35. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
36. Exploring the role of electrostatic deposition on inhaled aerosols in alveolated microchannels.
Bessler R; Bhardwaj S; Malka D; Fishler R; Sznitman J
Sci Rep; 2023 Dec; 13(1):23069. PubMed ID: 38155187
[TBL] [Abstract][Full Text] [Related]
37. Emerging inhalation aerosol devices and strategies: where are we headed?
Zhou QT; Tang P; Leung SS; Chan JG; Chan HK
Adv Drug Deliv Rev; 2014 Aug; 75():3-17. PubMed ID: 24732364
[TBL] [Abstract][Full Text] [Related]
38. Targeted drug-aerosol delivery in the human respiratory system.
Kleinstreuer C; Zhang Z; Donohue JF
Annu Rev Biomed Eng; 2008; 10():195-220. PubMed ID: 18412536
[TBL] [Abstract][Full Text] [Related]
39. A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations.
Hein S; Bur M; Schaefer UF; Lehr CM
Eur J Pharm Biopharm; 2011 Jan; 77(1):132-8. PubMed ID: 20951200
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery.
Willis L; Hayes D; Mansour HM
Lung; 2012 Jun; 190(3):251-62. PubMed ID: 22274758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
